Mulberry Developments acquires GlaxoSmithKline site in Harlow

Mulberry Property Developments (Mulberry Developments) is pleased to announce the successful acquisition of the former GlaxoSmithKline South site in Harlow, Essex. The site extends to 44.6 acres and includes approximately 326,704 sq ft of industrial/R&D space, which has been leased back to GlaxoSmithKline. With approximately 29 acres available for a new industrial/logistics/data centre development – subject…

Details